According to the European Environment Agency (EEA), household products, cosmetics, pharmaceuticals and food all contain endocrine disrupting chemicals (EDCs) which may be causing significant increases in diabetes, obesity, cancers and increasing infertility. In recent decades, the incidence of many human diseases and disorders including diabetes, breast and prostate cancer, ...

InDex Pharmaceuticals today announced that it has been granted a patent by the United States Patent and Trademark Office. The patent provides additional protection for the use of Kappaproct® and additional DNA-based immunomodulatory sequences (DIMS) for the treatment of steroid-resistant inflammatory diseases including inflammatory bowel disease, rheumatoid arthritis, psoriasis, ...

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated with minimal side effects and demonstrated efficacy in patients with castration-resistant prostate cancer (CRPC) in a Phase 1 study.

CAMBRIDGE, Mass. and CHICAGO, Ill. -- Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated with minimal side effects and demonstrated efficacy in patients with castration-resistant prostate cancer (CRPC) in a Phase 1 study. The ...

(Pure Communications Inc.) Tokai Pharmaceuticals, Inc. announced that its lead candidate galeterone was well-tolerated with minimal side effects and demonstrated efficacy in patients with castration-resistant prostate cancer in a Phase one study. The data will be presented in an oral presentation titled, "ARMOR1: Safety of galeterone (TOK-001) in a Phase ...

Escherichia coli – a bacteria considered the food safety bane of restaurateurs, grocers and consumers – is a friend. Cornell University biomolecular engineers have learned to use E. coli to produce sugar-modified proteins for making pharmaceuticals cheaper and faster. (Nature Chemical Biology, March 25, 2012.)

Escherichia coli a bacteria considered the food safety bane of restaurateurs, grocers and consumers is a friend. Cornell University biomolecular engineers have learned to use E. coli to produce sugar-modified proteins for making pharmaceuticals cheaper and faster. ( Nature Chemical Biology , March 25, 2012.) ...

Bactiguard has signed an exclusive co-operation with Cadila Pharmaceuticals, one of the largest healthcare manufacturing groups in India. A signing process will take place at the Swedish Ambassador's residency tonight.

Usually, mould fungi are nothing to cheer about - but now they can be used as "chemical factories". Scientists at the Vienna University of Technology have succeeded in introducing bacterial genes into the fungus Trichoderma, so that the fungus can now produce important chemicals for the pharmaceutical industry. The raw ...

(Vienna University of Technology) The pharmaceutical NANA is 50 times more expensive than gold. Now it can be produced from chitin - a very cheap natural resource. The process was made possible by genetically modifying mold fungi.

Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little. Some will die; a number will suffer debilitating aftereffects. Now, preliminary results of a Phase 2 clinical trial using Remedy Pharmaceuticals' new drug, RP-1127, presented at the 2012 International Stroke ...

HARTFORD, Conn., Jan. 19, 2012 /PRNewswire-iReach/ -- Global Information Inc. (GII) is pleased to announce a series of forthcoming conferences and networking events in the pharmaceuticals and biotechnology focus areas. These international industry events provide a platform for researchers and decision makers in biotechnology and pharmaceuticals to present ...